PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Liver Diseases Center, Sheba Medical Center, Tel Aviv, Israel.\', \'Infectious Diseases Unit, Sheba Medical Center, Tel Aviv, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.\', \'The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel.\', \'Central Virology Laboratory, Ministry of Health, Tel-Hashomer, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/lt.26366
?:hasPublicationType
?:journal
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
is ?:pmid of
?:pmid
?:pmid
  • 34767690
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all